PUBLISHER: 360iResearch | PRODUCT CODE: 1600933
PUBLISHER: 360iResearch | PRODUCT CODE: 1600933
Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-User - Global Forecast 2025-2030
The Human Organoids Market was valued at USD 594.84 million in 2023, expected to reach USD 703.34 million in 2024, and is projected to grow at a CAGR of 19.94%, to USD 2,124.91 million by 2030.
Human organoids are three-dimensional, miniaturized versions of organs derived from stem cells, mimicking actual organ function and structure. These cutting-edge models represent an intersection of biology and technology, offering unprecedented advancements in understanding human diseases, drug development, and personalized medicine. The increasing necessity for human organoids stems from their capability to provide more accurate in vitro models than traditional 2D cultures, aiding research into complex human-specific infections, cancer, and neurodegenerative diseases. Subsequently, their applications span pharmaceutical and biotechnology industries, academic research, and regenerative medicine. Key end-users include drug manufacturers, academic and research institutes, and hospitals.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 594.84 million |
| Estimated Year [2024] | USD 703.34 million |
| Forecast Year [2030] | USD 2,124.91 million |
| CAGR (%) | 19.94% |
The market's growth is strongly influenced by continuous advancements in stem cell technologies, increasing demand for personalized medicine, and government funding supporting research initiatives. Moreover, the COVID-19 pandemic underscored the demand for better human-specific models to study viral infections, benefiting the market. Profound opportunities exist in the expansion of organoid technology for chronic disease modeling, personalized drug screening, and toxicity testing, creating avenues for strategic collaborations between biotech firms and academic institutions.
Nevertheless, challenges such as high development costs, technical complexities in 3D culture maintenance, ethical considerations regarding stem cell usage, and a lack of standardized protocols hinder market expansion. Addressing these limitations through industry-wide collaborations and regulatory advancements could drive growth. Innovations including CRISPR-based genetic editing, organoid-on-a-chip platforms, and integration with artificial intelligence for big data analysis represent fertile areas for research and development. The nature of the market remains dynamic and competitive, driven by rapid technological advancements and strategic partnerships. Businesses should focus on investing in technology that ensures reproducibility and scalability of organoids, and on enhancing collaboration between multidisciplinary teams to leverage varied expertise, thereby reinforcing their market position and capitalizing on emerging opportunities.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Organoids Market
The Human Organoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- High need for developing alternatives for animal testing models
- Rising focus toward improving disease models and drug discovery
- Market Restraints
- Limited availability of skilled workforce
- Market Opportunities
- Significant increase in research funding and capital investments for the development of human organoids
- Potential application of human organoids for biocomputing
- Market Challenges
- Issues related to current organoid technology
Porter's Five Forces: A Strategic Tool for Navigating the Human Organoids Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Organoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Human Organoids Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Organoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Human Organoids Market
A detailed market share analysis in the Human Organoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Organoids Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Organoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Key Company Profiles
The report delves into recent significant developments in the Human Organoids Market, highlighting leading vendors and their innovative profiles. These include 3Dnamics Inc., AIVITA Biomedical, Inc., BICO Group AB, Bio-Techne Corporation, BioIVT LLC, BrainZell, Cannex Scientific, Inc., CN Bio Innovations Limited, Corning Incorporated, DefiniGEN Limited, F. Hoffmann-La Roche Ltd., HeartBeat.bio AG, Herophilus, HUB Organoids B.V., InSphero AG, Kirkstall Ltd., Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., PerkinElmer, Inc., PRIMACYT Cell Culture Technology GmbH, Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Holdings Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..
Market Segmentation & Coverage
This research report categorizes the Human Organoids Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Colorectal, Heart, Kidney, Liver, and Pancreas.
- Based on Usability, market is studied across Customizable Products and Ready to Use Products.
- Based on Application, market is studied across Developmental Biology, Disease Pathology, Drug Toxicity & Efficacy Testing, Personalized Medicine, and Regenerative Medicine.
- Based on End-User, market is studied across Academic & Research Institutes, Clinical Research Organizations, and Pharmaceutical & Biotechnology Companies.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. High need for developing alternatives for animal testing models
- 5.1.1.2. Rising focus toward improving disease models and drug discovery
- 5.1.2. Restraints
- 5.1.2.1. Limited availability of skilled workforce
- 5.1.3. Opportunities
- 5.1.3.1. Significant increase in research funding and capital investments for the development of human organoids
- 5.1.3.2. Potential application of human organoids for biocomputing
- 5.1.4. Challenges
- 5.1.4.1. Issues related to current organoid technology
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Emerging crucial role of liver organoids in pharmacology and toxicology studies
- 5.2.2. Application: Increasing adoption of human organoids in drug toxicity and efficacy testing to improve patient care and safety
- 5.2.3. Usability: Increasing usage of customizable products that allow researchers to tailor organoid cultures to their specific needs
- 5.2.4. End-User: Rising need for human organoids across academic & research institutions for identifying novel drug targets and understanding disease progression
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Human Organoids Market, by Product
- 6.1. Introduction
- 6.2. Colorectal
- 6.3. Heart
- 6.4. Kidney
- 6.5. Liver
- 6.6. Pancreas
7. Human Organoids Market, by Usability
- 7.1. Introduction
- 7.2. Customizable Products
- 7.3. Ready to Use Products
8. Human Organoids Market, by Application
- 8.1. Introduction
- 8.2. Developmental Biology
- 8.3. Disease Pathology
- 8.4. Drug Toxicity & Efficacy Testing
- 8.5. Personalized Medicine
- 8.6. Regenerative Medicine
9. Human Organoids Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Clinical Research Organizations
- 9.4. Pharmaceutical & Biotechnology Companies
10. Americas Human Organoids Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
11. Asia-Pacific Human Organoids Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
12. Europe, Middle East & Africa Human Organoids Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. Transforming Disease Research and Drug Discovery with Sinai Health's USD 10 Million Investment in Lab-Grown Organoids
- 13.3.2. Partnership Advances Cardiac Safety Testing in Drug Development: ATCC and Tissue Dynamics Collaboration
- 13.3.3. Advancing Drug Safety with Human Liver Organoid Technology: CuSTOM and Danaher Corporation's Innovative Collaboration
- 13.3.4. Revolutionary Advancements in Neurodegenerative Disease Modeling Through Stem Cell-Derived Brain Organoids
- 13.3.5. Advancing Precision Medicine with Launch of a State-of-the-Art Organoid Facility for Next-Generation Disease Modeling
- 13.3.6. Roche's Revolutionary Launch: The Institute of Human Biology to Propel Medical Research with Organoid Technology
- 13.3.7. Roche Launches Institute of Human Biology in Basel to Revolutionize Drug Discovery with Organoid and Human Model System Research
- 13.3.8. New Frontiers by National Science Foundation's Directorate for Engineering: From Organoid Intelligence to Tailored Learning
- 13.3.9. Molecular Devices Partners with HUB Organoids to Advance 3D Biology Technologies
- 13.3.10. Innovating Drug Discovery: Molecular Devices and HUB Organoids Forge Strategic Partnership
Companies Mentioned
- 1. 3Dnamics Inc.
- 2. AIVITA Biomedical, Inc.
- 3. BICO Group AB
- 4. Bio-Techne Corporation
- 5. BioIVT LLC
- 6. BrainZell
- 7. Cannex Scientific, Inc.
- 8. CN Bio Innovations Limited
- 9. Corning Incorporated
- 10. DefiniGEN Limited
- 11. F. Hoffmann-La Roche Ltd.
- 12. HeartBeat.bio AG
- 13. Herophilus
- 14. HUB Organoids B.V.
- 15. InSphero AG
- 16. Kirkstall Ltd.
- 17. Merck KGaA
- 18. Miltenyi Biotec B.V. & CO. KG
- 19. Mimetas BV
- 20. Molecular Devices, LLC by Danaher Corporation
- 21. Neurxstem Inc.
- 22. Organovo Holdings Inc.
- 23. Pandorum Technologies Pvt. Ltd.
- 24. PerkinElmer, Inc.
- 25. PRIMACYT Cell Culture Technology GmbH
- 26. Rumi Scientific, Inc.
- 27. STEMCELL Technologies Canada Inc.
- 28. SUN bioscience SA.
- 29. Takara Holdings Inc.
- 30. Thermo Fisher Scientific Inc.
- 31. ZenBio, Inc.
LIST OF FIGURES
- FIGURE 1. HUMAN ORGANOIDS MARKET RESEARCH PROCESS
- FIGURE 2. HUMAN ORGANOIDS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
- FIGURE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 6. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 14. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 16. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 17. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 18. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
- FIGURE 22. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 23. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. HUMAN ORGANOIDS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
- TABLE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
- TABLE 6. HUMAN ORGANOIDS MARKET DYNAMICS
- TABLE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY READY TO USE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 18. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DISEASE PATHOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 19. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 20. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 21. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 22. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 23. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 24. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 25. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD THOUSAND)
- TABLE 26. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 27. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 28. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 29. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 30. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
- TABLE 31. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 32. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 33. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 34. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 35. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 36. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 37. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 38. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 39. CANADA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 40. CANADA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 41. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 42. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 43. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 44. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 45. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 46. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 47. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 48. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 49. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 50. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 51. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
- TABLE 52. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 53. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 54. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 55. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 56. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
- TABLE 57. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 58. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 59. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 60. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 61. CHINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 62. CHINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 63. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 64. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 65. INDIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 66. INDIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 67. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 68. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 69. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 70. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 71. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 72. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 73. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 74. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 75. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 76. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 77. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 78. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 79. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 80. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 81. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 82. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 83. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 84. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 85. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 86. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 87. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 88. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 89. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 90. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 91. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 92. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 93. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 94. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 95. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 96. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 97. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 98. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 99. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 100. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 101. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 102. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 103. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 104. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 108. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 109. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
- TABLE 110. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 111. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 112. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 113. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 114. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 115. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 116. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 117. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 118. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 119. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 120. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 121. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 122. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 123. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 124. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 125. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 126. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 127. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 128. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 129. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 130. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 131. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 132. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 133. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 134. ITALY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 135. ITALY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 136. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 137. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 138. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 139. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 140. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 141. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 142. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 143. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 144. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 145. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 146. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 147. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 148. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 149. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 150. POLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 151. POLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 152. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 153. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 154. QATAR HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 155. QATAR HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 156. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 157. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 158. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 159. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 160. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 161. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 162. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 163. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 164. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 165. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 166. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 167. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 168. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 169. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 170. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 171. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 172. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 173. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 174. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 175. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 176. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 177. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 178. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 179. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 180. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 181. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 182. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 183. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 184. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 185. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 186. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 187. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 188. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 189. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 190. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
- TABLE 191. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
- TABLE 192. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
- TABLE 193. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
- TABLE 194. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 195. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023
